Znomics, University of Utah — Huntsman Cancer Institute, Nikon Instruments, A.G. Heinze, Assay Designs, Medical University of South Carolina, Amnis, Gene Company, BioFocus DPI, Allergan, State Street Bank, Applied Biosystems | GenomeWeb
Znomics, University of Utah Ink Drug Discovery Deal
Znomics announced this week a collaborative research program with the University of Utah and its Huntsman Cancer Institute to develop pre-clinical compounds for the treatment of T-cell leukemia, autoimmune diseases, inflammation, and complications related to organ transplantation.
Financial terms of the collaboration were not disclosed. However, Znomics will fund the program and receive full commercial rights to the discoveries.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.